Keeping Track: Ticovac Is Latest Win For Pfizer’s Vaccine Business; Doors Open For BMS And GSK PD-1 Inhibitors

 
• By Bridget Silverman
  
Keeping Track Feature image
GlaxoSmithKline’s Jemperli joined the small group of products with tissue-agnostic cancer therapy indications in the US.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews